Inno4Life receives funding for serialization in pharmacy and international growth

BOM, TIIN Capital, Holland Venture and the Zeeuws Investment Fund (ZIF) invest in life science machine building company.

Breda, September 4, 2017 – Inno4Life, machine building company in the life science industries, will receive an investment from the Brabant Development Agency (BOM), Holland Venture, TIIN Capital and the Zeeuws Investment Fund. Inno4Life uses the investment for the development of serialization equipment solutions in packaging machines for medicines and to accelerate the international growth of the company.
Inno4Life provides integrated tailor-made solutions and machines that meet the ever changing needs within the Life Sciences sector, especially in the pharmaceutical and biotech industries. The machines and automation solutions from Inno4Life include packaging processes for track & tracing of medicines. Inno4Life develops and builds machines for the top ten pharmaceutical companies worldwide. The organization offers solutions to companies in various areas e.g. automated filling systems, loading systems and fits robot and vision technology.
The pharmaceutical industry is continuously changing as a result of mergers or reorganizations. The level of automation intensifies, prices are under pressure and legislation is getting stricter. Johan Klootwijk, CEO Inno4Life: “Innovations in production processes are necessary for pharmaceutical companies. Companies have to comply with increasingly strict legislation and at the same time produce more efficiently and more effectively than competitors. Partly because of these developments, it is essential that specialist suppliers innovate continuously.”

Ewout Prins, managing partner Holland Venture, indicates: “Inno4Life has a vision on the Life Sciences market, based management’s extensive experience. We have faith in the company’s growth strategy. As a young and innovative company, Inno4Life has acquired a distinctive strategic position within a knowledge-driven niche market, delivering to the top 10 international pharmaceutical companies. An impressive performance. In the current market we see a clear momentum for further growth and expansion, and we are looking forward to actively supporting Inno4Life.”

Innovation by new legislation
In 2019 all packages of prescription medicines need to be provided with a unique code. Pharmaceutical manufacturers print these unique codes on the packaging. Pharmacists scan this unique code to determine the authenticity of the medicine before they give it to patients. Inno4Life provides expertise and solutions for pharmaceutical companies to meet this new legislation.

“Our ambition is to increase our reputation as an international supplier of automated production equipment,” continues Klootwijk. “By leading the way in providing customer specific, innovative solutions with exceptional customer service, we offer our customers the best possible service. With the knowledge and the capital of these investors we can pursue our international growth ambitions.”

About Holland Venture
Holland Venture has invested in more than 130 Dutch SMEs in a responsible and successful manner over the past 35 years. With a clear investment strategy, Holland Venture is active in the attractive growth markets of Healthcare and Technology. The experienced and involved investment team knows what entrepreneurship is like. Holland Venture strives for an open, sustainable and professional relationship with the management teams of the companies in which she invests, with the joint goal of achieving growth. Holland Venture is supported by a broad network of successful entrepreneurs in Healthcare and Technology.